Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
about
HIV-1 Vaccine Trials: Evolving Concepts and DesignsCurrent progress in the development of a prophylactic vaccine for HIV-1.NMR structure of the myristylated feline immunodeficiency virus matrix protein.Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccineDeterminants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjectsReplacement of the V3 domain in the surface subunit of the feline immunodeficiency virus envelope glycoprotein with the equivalent region of a T cell-tropic human immunodeficiency virus type 1 results in a chimeric surface protein that efficiently bInterplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals.Domestic animal models for biomedical research.Feline immunodeficiency virus latency.Dissecting evolution and disease using comparative vertebrate genomics.An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?Duration of antibody response following vaccination against feline immunodeficiency virus.Shell disorder, immune evasion and transmission behaviors among human and animal retroviruses.Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodiesFIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review.
P2860
Q30425520-031183D6-B25F-483E-9E01-FAB3AEAFCA79Q34502108-3D3889E1-3F9F-4A57-822F-855BF2DAA7BDQ35675988-A9F5BE20-F8B7-49A8-8159-DA2A4EACDA92Q35709133-FD973EAC-221E-47F1-A9BC-3D78F36BB5E0Q37059673-1DA3A9E7-56C7-41E9-98AF-3596306850DCQ37123133-4600FFD7-E827-4DBB-8C50-5309EDF36399Q37610630-72DD6635-BD98-4293-8E4F-52860D7E9205Q37735221-47E4C180-F2E3-461A-9D4F-4152BAE29E4FQ38029020-68E6CA70-BF23-438D-AC9E-8C9612FA8A51Q38119498-7919A861-236B-44D8-9509-8450EA3BDEC2Q38652964-94002097-9A9C-4C7B-A58B-7566D75D0625Q38730613-8BB8AA00-84FD-49D0-A16C-88A953CF94D3Q38746224-1B45CA10-B196-4CEC-AE50-4096F5FB06B3Q38795312-7433F3F4-D2F6-4541-98D1-C3840D7413F9Q40492566-C4A2A763-E3FF-45FE-B49E-DF4D1DA5D326Q41157592-820722C9-34FD-48D0-BD89-210A8DA2543BQ42257512-8ED81EED-BB4C-4DA6-9A87-5709F526FD9AQ53686365-4F099C9F-430E-4BEF-BF45-2CB3DE805B69Q54942553-EFC8888D-0264-48F1-8FFB-E455A3CCDFD0
P2860
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@en
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@nl
type
label
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@en
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@nl
prefLabel
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@en
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@nl
P2093
P2860
P1433
P1476
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
@en
P2093
James K Coleman
Janet K Yamamoto
Jeffrey R Abbott
Missa P Sanou
P2860
P356
10.2174/157016210790416361
P577
2010-01-01T00:00:00Z